Baclofen for alcohol use disorder
Abstract
None of the primary or secondary outcomes of the review showed evidence of a difference between baclofen and placebo. The high heterogeneity among primary studies results limits the interpretation of the summary estimate, the identification of moderators and mediators of baclofen's effects on alcoho …
Keywords
systematic review
meta-analysis
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
male
middle aged
Recurrence
randomized controlled trials as topic
alcohol drinking / prevention & control*
patient dropouts / statistics & numerical data
baclofen / adverse effects
baclofen / therapeutic use*
alcoholism / drug therapy*
gaba-b receptor agonists / therapeutic use*
gaba-b receptor agonists / adverse effects
pmid:30484285
pmc6517285
doi:10.1002/14651858.cd012557.pub2
silvia minozzi
rosella saulle
susanne rösner
acamprosate / therapeutic use
alcohol deterrents / adverse effects
alcohol deterrents / therapeutic use*
craving / drug effects
depression / chemically induced
Citation
ID:
271892
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
271892
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet